As the Omicron coronavirus variant spreads in southern Africa and pops up in countries all around the world, scientists are anxiously watching a battle play out that could determine the future of the pandemic. Can the latest competitor to the world-dominating Delta overthrow it? Some scientists, poring over data from…
Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.
FRANKFURT: Three doses of the Pfizer-BioNTech coronavirus vaccine appear effective against the omicron variant, a lab test indicated encouraging news, even as Denmark and Britain announced new restrictions to stem surging caseloads. In preliminary results published on Wednesday, the US and German companies behind one of the world’s foremost shots to combat Covid-19 said a
Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron strain, the companies warned Wednesday, but they stressed it was “still effective” after a third jab. The companies’ news was called reassuring by experts, and came as the first independent data from labs around the world emerged, […]
Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.